NCT06828549
MObile Support Adapted to Individual Contexts
Enrolling by Invitation
NAAges 18–75InterventionalSupportive careVanderbilt University Medical CenterInvestigator-initiated
~547 participants
Updated 2026-03-05 on ClinicalTrials.gov
What's tested:MOSAICPrint Materials
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Hemoglobin A1c During Intervention Period
Measured over Baseline and 4, 8, and 12 months post-baseline
+1 more outcome measured
Conditions
Where it's being run
2 sites across 2 statesAlabama1
Tennessee1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Speaks and reads in English
18-75 years old
Diagnosed with type 2 diabetes
Receiving outpatient care from a partnering clinic
Community-dwelling (e.g., not in a nursing facility)
Prescribed at least one diabetes medication
Owns a mobile phone
Speaks and reads in English
18 years or older
Owns a mobile phone
Exclusion
Unable to communicate by phone
Currently pregnant
Currently undergoing treatment for cancer (e.g., radiation, chemotherapy)
Diagnosed with end-stage renal disease
Receiving hospice services\*
Diagnosed with congestive heart failure
Diagnosed with dementia
Diagnosed with schizophrenia
Demonstrated an inability to receive and respond to a text
Does not take medication on his/her own/medication administered by someone else
Demonstrated inability to receive \& respond to a text
Unable to communicate by phone
What this trial measures
- Change in Hemoglobin A1c During Intervention PeriodBaseline and 4, 8, and 12 months post-baseline
Hemoglobin A1c assessed by mail-in A1c kits and/or taken from electronic health record (venipuncture or point-of-care) where higher values indicate worse glycemic management
- Change in Hemoglobin A1c Sustained Post-intervention EffectsBaseline and 16 months post-baseline
Hemoglobin A1c assessed by mail-in A1c kits and/or taken from electronic health record (venipuncture or point-of-care) where higher values indicate worse glycemic management